VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Anbio Biotechnology Class A Ordinary Shares (NNNN) Total Return Calculator with Dividends Reinvested

Anbio Biotechnology Class A Ordinary Shares

Popular:

The total return for Anbio Biotechnology Class A Ordinary Shares (NNNN) stock is +362.76% over the past 12 months. So far it's down 0.95% this year. The 5-year total return is +406.07%, meaning $10,000 invested in NNNN stock 5 years ago would be worth $50,607 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in NNNN 1 year ago, it would be worth $44,444 today — you'd have gained $34,444.

With Dividends Reinvested$44,444+344.44%

Price Only (No DRIP)$44,444+344.44%

Period2025-05-06 → 2026-05-05

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in NNNN

1Y$46,276+$36,276 (+362.8%)362.8% CAGR

3Y$50,607+$40,607 (+406.1%)71.7% CAGR

5Y$50,607+$40,607 (+406.1%)38.3% CAGR

10Y$50,606+$40,606 (+406.1%)17.6% CAGR

15Y$50,607+$40,607 (+406.1%)11.4% CAGR

20Y$50,607+$40,607 (+406.1%)8.4% CAGR

30Y$50,606+$40,606 (+406.1%)5.6% CAGR

Anbio Biotechnology Class A Ordinary Shares did not pay dividends during this period. Total return = price return.

Loading NNNN total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-0.95%	—	-0.95%	—	$9,905
1Y	+362.76%	362.76%	+362.76%	—	$46,276
3Y	+406.07%	71.69%	+406.07%	—	$50,607
5Y	+406.07%	38.31%	+406.07%	—	$50,607
10Y	+406.06%	17.60%	+406.06%	—	$50,606
15Y	+406.07%	11.42%	+406.07%	—	$50,607
20Y	+406.07%	8.45%	+406.07%	—	$50,607
30Y	+406.06%	5.55%	+406.06%	—	$50,606

Risk & Highlights

Best Year+421.14%2025

Max Drawdown-76.41%2025-08-19 → 2025-11-03

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-12.62%	-12.62%	—	+0.41%	-13.0pp
2025	+421.14%	+421.14%	—	+16.64%	+404.5pp

NNNN outperformed the S&P 500 by 334.32pp over the past year (+362.76% vs +28.44%).

Loading summary...

NNNN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
NNNNAnbio Biotechnology Class A Ordinary Shares	$1.3B	+11.7%	-0.9%	+362.8%	—	+406.1%	+406.1%	+406.1%
CLOVClover Health Investments, Corp.	$1.3B	+39.6%	+8.3%	-22.1%	—	+222.2%	-70.5%	-74.4%
ACHCAcadia Healthcare Company, Inc.	$2.3B	+1.4%	+76.8%	+10.8%	—	-63.5%	-59.7%	-56.5%
QDELQuidelOrtho Corporation	$794M	-26.6%	-59.5%	-57.9%	—	-86.8%	-89.6%	-27.5%
CHEKCheck-Cap Ltd.	$12M	—	+21.3%	+133.9%	—	+49.6%	-93.2%	-99.7%
IDXXIDEXX Laboratories, Inc.	$44.8B	-2.5%	-16.0%	+18.5%	—	+15.2%	+6.2%	+553.6%
BIOBio-Rad Laboratories, Inc.	$6.9B	-7.8%	-15.8%	+7.0%	—	-33.3%	-57.2%	+79.3%
NEOGNeogen Corporation	$2.0B	-3.0%	+32.4%	+64.4%	—	-46.8%	-80.2%	-48.2%
ALGNAlign Technology, Inc.	$12.1B	-1.8%	+8.1%	-5.0%	—	-46.2%	-70.4%	+123.3%
HOLXHologic, Inc.	$17.0B	+0.0%	+1.9%	+44.1%	—	-9.2%	+16.0%	+125.2%
TMOThermo Fisher Scientific Inc.	$173.5B	-4.4%	-21.1%	+11.0%	+0.4pp	-13.7%	+1.3%	+229.0%

Compare:NNNN vs CLOV NNNN vs ACHC NNNN vs QDEL NNNN vs CLOV vs ACHC

About NNNN Dividend Returns

Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of NNNN over the past year?

Anbio Biotechnology Class A Ordinary Shares (NNNN) delivered a return of 362.76% over the past year. Since NNNN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in NNNN be worth today?

A $10,000 investment in Anbio Biotechnology Class A Ordinary Shares one year ago would be worth $46,276 today, representing a gain of $36,276.

Q3Does NNNN pay dividends?

Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For NNNN, the total return equals the price-only return.

Q4Did NNNN beat the S&P 500?

Yes, Anbio Biotechnology Class A Ordinary Shares (NNNN) outperformed the S&P 500 by 334.32 percentage points over the past year. NNNN delivered a total return of 362.76%, compared to the S&P 500's 28.44%. This 334.32pp alpha means investors in NNNN earned more than a passive S&P 500 index fund.

Q5What is NNNN's worst drawdown?

Anbio Biotechnology Class A Ordinary Shares (NNNN) experienced a maximum drawdown of -76.41% over the past year, declining from its peak on 2025-08-19 to its trough on 2025-11-03. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is NNNN's long-term total return over 10, 20, or 30 years?

Here are Anbio Biotechnology Class A Ordinary Shares (NNNN)'s long-term returns with dividends reinvested. Over 10 years, the total return is 406.1% (17.6% CAGR) — $10,000 would have grown to $50,606. Over 20 years: 406.1% total return (8.4% CAGR) — $10,000 → $50,607. Over 30 years: 406.1% total return (5.6% CAGR) — $10,000 → $50,606. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.